Clinical trial
Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral…
NCT00381719 · Allergan, Industry · Completed
Key facts
| NCT number | NCT00381719 |
|---|---|
| Title | Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy |
| Lead sponsor | Allergan, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Neuropathy, Painful |
| Intervention type | Drug |
| Interventions | AGN 203818, placebo capsule |
| Enrollment | 330 |
| Start date | Oct 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Sep 28, 2006 |
| Last update posted | Jan 7, 2008 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: